Study to Investigate the Pharmacokinetics, Safety, and Tolerability of BMT101 in Healthy Male Volunteers

Status:
Completed

Trial end date:
2018-02-14

Target enrollment:

Participant gender:

Phase I Study to Investigate the Pharmacokinetics, Safety, and Tolerability of BMT101 in Healthy Male Volunteers

Phase 1

Hugel